Evidence for IL-6 promoter nuclear activation in U937 cells stimulated with Salmonella enterica serovar Typhimurium porins

European Cytokine Network

Volumn 20, Issue 3, 2009, Pages 140-147

  Finamore, Emiliana ^a   Vitiello, Mariateresa ^a   D'Isanto, Marina ^a   Galdiero, Emilia ^b   Falanga, Annarita ^b   Kampanaraki, Aikaterini ^a   Raieta, Katia ^a   Galdiero, Marilena ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

IL 6; NF B; Nuclear activation; Porins

Indexed keywords

INTERLEUKIN 6; PORIN; TRANSCRIPTION FACTOR RELA;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HOST SUSCEPTIBILITY; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SALMONELLA ENTERICA; SALMONELLOSIS; SEROTYPE;

CELL NUCLEUS; CONSENSUS SEQUENCE; DENSITOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; NF-KAPPA B; PORINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA, MESSENGER; SALMONELLA TYPHIMURIUM; SIGNAL TRANSDUCTION; U937 CELLS;

NEGIBACTERIA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

EID: 70849135412     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2009.0158     Document Type: Article

References (35)

1. Galdiero M, D'Isanto M, Vitiello M, et al. Role of bacterial porins in the inflammatory and immunological responses. Recent Develop Immunol 2004; 6: 1.
2. Ramos HC, Rumbo M, Sirard JC. Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. Trends Microbiol 2004; 12: 509.
3. Remick DG, Bolgos GR, Siddiqui J, et al. Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock 2002; 17: 463.
4. Turnbull IR, Javadi P, Buchman TG, et al. Antibiotics improve survival in sepsis independent of injury severity but do not change mortality in mice with markedly elevated interleukin 6 levels. Shock 2004; 21: 121.
5. Galdiero M, Galdiero M, Finamore E, et al. Haemophilus influenzae porin induces Toll-like receptor 2-mediated cytokine production in human monocytes and mouse macrophages. Infect Immun 2004; 72: 1204. (Pubitemid 38166712)
6. Ozato K, Tsujimura H, Tamura T. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system. Biotechniques 2002; (Suppl. 66).
7. Tanabe O, Akira S, Kamiya T, et al. Genomic structure of the murine IL-6 gene. High degree conservation of potential regulatory sequences between mouse and human. J Immunol 1998; 141: 3875.
8. Dendorfer U, Oettgen P, Libermann TA. Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol Cell Biol 1994; 14: 4443.
9. Vanden Berghe W, Vermeulen L, De Wilde G, et al. Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. Biochem Pharmacol 2000; 60: 1185.
10. Walev I, Vollmer P, Palmer M, et al. Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide. Proc Natl Acad Sci USA 1996; 93: 7882.
11. Galdiero M, Vitiello M, D'Isanto M, et al. Induction of tyrosine phosphorylated proteins in THP-1 cells by Salmonella typhimurium, Pasteurella haemolytica and Haemophilus influenzae porins. FEMS Immunol Med Microbiol 2001; 13: 121.
12. Galdiero M, Vitiello M, Sanzari E, et al. Porins from Salmonella enterica serovar Typhimurium activate the transcription factors activating protein 1 and NF-kappaB through the Raf- 1-mitogen-activated protein kinase cascade. Infect Immun 2002; 70: 558. (Pubitemid 34083814)
13. Galdiero M, Vitiello M, D'Isanto M, et al. STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and play a role in U937 cells production of interleukin-6. Cytokine 2006; 36: 218. (Pubitemid 46529473)
14. Caamano J, Hunter CN. -κB family of transcription factors: central regulators of innate and adaptive immune functions. Clin Microbiol Rev 2002; 15: 419.
15. Lowry OH, Rosebrough NJ, et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265.
16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 1970; 277: 680.
17. Tsai CM, Frasch CE. A sensitive silver-stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem 1982; 119: 115.
18. Yin ET, Galanos C, Kinsky S, et al. Picogram sensitive assay for endotoxin: gelation of Limulus polyphemus blood cell lysate induced by purified lipopolysaccharide and lipid A from Gram negative bacteria. Biochim Biophys Acta 1972; 261: 284.
19. Morrison DC, Jacobs DM. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochem 1976; 13: 813.
20. Natarajan K, Singh S, Burke Jr TR, et al. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci USA 1996; 93: 9090. (Pubitemid 26282023)
21. Kobori M, Yang Z, Gong D, et al. Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complex. Cell Death Differ 2004; 11: 123. (Pubitemid 38111379)
22. Renard P, Ernest I, Houbion A, et al. Development of a sensitive multi-well colorimetric assay for active NF-κB. Nucleic Acids Res 2001; 29: E21.
23. Sheppard KA, Rose DW, Haque ZK, et al. Transcriptional activation by NF-kappaB requires multiple co-activators. Mol Cell Biol 1999; 19: 6367.
24. Giannitrapani L, Cervello M, Soresi M, et al. Circulating IL-6 and sIL-6R in patients with hepatocellular carcinoma. Ann NY Acad Sci 2002; 963: 46.
25. Hoffmann JA, Kafatos FC, Janeway CA, et al. Phylogenetic perspectives in innate immunity. Science 1999; 284: 1313.
26. Zhang G, Ghosh S. Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest 2001; 107: 13. (Pubitemid 32047406)
27. Lauta VM. Interleukin-6 and the network of several cytokines in multiple myeloma: an overview of clinical and experimental data. Cytokine 2001; 16: 79.
28. Fraser CC. Exploring the positive and negative consequences of NF-kappaB inhibition for the treatment of human disease. Cell Cycle 2006; 5: 1160.
29. Zingarelli B, Sheehan M, Wong HR. Nuclear factor-kappaB as a therapeutic target in critical care medicine. Crit Care Med 2003; 31: S105. (Pubitemid 36143484)
30. Egan LJ, Toruner M. NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach. Ann NY Acad Sci 2006; 1072: 114.
31. Edwards MR, Bartlett NW, Clarke D, et al. Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. Pharmacol Ther 2009; 121: 1.
32. Vitiello M, D'Isanto M, Galdiero M, et al. Interleukin-8 production by THP-1 cells stimulated by Salmonella enterica serovar Typhimurium porins is mediated by AP-1, NF-kappaB and MAPK pathways. Cytokine 2004; 27: 15.
33. Chatterjee-Kishore M, Wright KL, Ting JP, et al. How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene. EMBO J 2000; 19: 4111. (Pubitemid 30608549)
34. Yang J, Chatterjee-Kishore M, Staugaitis SM, et al. Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation. Cancer Res 2005; 65: 939. (Pubitemid 40216455)
35. Xiao H, Siddiqui J, Remick DG. Mechanisms of mortality in early and late sepsis. Infect Immun 2006; 74: 5227. (Pubitemid 44300441)